C33H35N5O6
Neat
597.67
Room Temperature
8-Hydroxyergotamine; 72170-28-6; 1A7852J6VH; UNII-1A7852J6VH; Ergotaman-3', 6', 18-trione, 8, 12'-dihydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-; ERGOTAMINE TARTRATE IMPURITY A [EP IMPURITY]; (6AR, 9S)-N-((2R, 5S, 10AS, 10BS)-5-BENZYL-10B-HYDROXY-2-METHYL-3, 6-DIOXOOCTAHYDRO-8H-(1, 3)OXAZOLO(3, 2-A)PYRROLO(2, 1-C)PYRAZIN-2-YL)-9-HYDROXY-7-METHYL-4, 6, 6A, 7, 8, 9-HEXAHYDROINDOLO(4, 3-FG)QUINOLINE-9-CARBOXAMIDE; ERGOTAMAN-3', 6', 18-TRIONE, 8, 12'-DIHYDROXY-2'-METHYL-5'-(PHENYLMETHYL)-, (5'.ALPHA.)-; ERGOTAMINE TARTRATE IMPURITY A (EP IMPURITY); RefChem:107171; (6aR, 9S)-N-[(1S, 2S, 4R, 7S)-7-benzyl-2-hydroxy-4-methyl-5, 8-dioxo-3-oxa-6, 9-diazatricyclo[7.3.0.02, 6]dodecan-4-yl]-9-hydroxy-7-methyl-4, 6, 6a, 8-tetrahydroindolo[4, 3-fg]quinoline-9-carboxamide; Ergotamine EP Impurity A; SCHEMBL25014716; Ergotamine Tartrate EP Impurity A; (6aR, 9S)-N-((2R, 5S, 10aS, 10bS)-5-benzyl-10b-hydroxy-2-methyl-3, 6-dioxooctahydro-8H-oxazolo[3, 2-a]pyrrolo[2, 1-c]pyrazin-2-yl)-9-hydroxy-7-methyl-4, 6, 6a, 7, 8, 9-hexahydroindolo[4 and 3-fg]quinoline-9-carboxamide
(6aR, 9S)-N-[(1S, 2S, 4R, 7S)-7-benzyl-2-hydroxy-4-methyl-5, 8-dioxo-3-oxa-6, 9-diazatricyclo[7.3.0.02, 6]dodecan-4-yl]-9-hydroxy-7-methyl-4, 6, 6a, 8-tetrahydroindolo[4 and 3-fg]quinoline-9-carboxamide
InChI=1S/C33H35N5O6/c1-31(30(41)38-25(14-19-8-4-3-5-9-19)28(39)37-13-7-12-26(37)33(38,43)44-31)35-29(40)32(42)16-22-21-10-6-11-23-27(21)20(17-34-23)15-24(22)36(2)18-32/h3-6,8-11,16-17,24-26,34,42-43H,7,12-15,18H2,1-2H3,(H,35,40)/t24-,25+,26+,31-,32+,33+/m1/s1